Vanda Pharmaceuticals Set for Major Investor Conferences Soon
Vanda Pharmaceuticals: Upcoming Investor Engagements
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has announced its participation in several pivotal investor conferences scheduled for September 2025. These gatherings present an excellent opportunity for the company to showcase its innovative approaches and connect with investors.
Details of the Scheduled Conferences
The first event on the agenda is the Cantor Global Healthcare Conference 2025, taking place in New York City. Vanda is set to deliver a corporate presentation on this occasion. Attendees can look forward to insights from the company at 3:55 p.m. Eastern Time on September 3, 2025.
Wells Fargo Healthcare Conference
Subsequently, Vanda will participate in the 2025 Wells Fargo Healthcare Conference in Boston, where it will present to investors on September 4, 2025, at 4:30 p.m. Eastern Time. This conference serves as another important platform for Vanda to discuss its pipeline and strategic focus.
H.C. Wainwright Global Investment Conference
On September 9, 2025, Vanda will continue its investor outreach at the H.C. Wainwright Annual Global Investment Conference, once again taking place in New York City. The presentation is scheduled for 8:30 a.m. Eastern Time, offering investors valuable information about the company's future direction and advancements.
Accessing Presentations Online
For those unable to attend in person, Vanda's corporate presentations at the Cantor, Wells Fargo, and H.C. Wainwright conferences will be accessible live on Vanda’s corporate website. Investors should navigate to the Investors tab and follow the link under Recent Events. It is recommended that they log on at least 15 minutes prior to the start time to ensure all necessary software is installed and any issues are resolved. Following the conferences, an archived version of the presentations will be available on the website for about 30 days.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a prominent player in the biotechnology sector, focused on developing innovative therapies that address significant unmet medical needs. The company is committed to improving the quality of life for patients by providing solutions through its comprehensive product development pipeline. Vanda's efforts emphasize the importance of research and development in delivering effective treatments to the market.
Furthermore, as part of its outreach, Vanda encourages interested parties to visit their official website for updates and further information on their initiatives. Following Vanda on social media also provides stakeholders with regular insights and news from the company.
Corporate Contact Information
For additional inquiries, Vanda Pharmaceuticals can be contacted through the following representatives:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Phone: 202-734-3400
Jim Golden, Jack Kelleher, Dan Moore
Collected Strategies
Frequently Asked Questions
What is Vanda Pharmaceuticals focused on?
Vanda Pharmaceuticals is dedicated to developing innovative therapies that address significant unmet medical needs.
When will Vanda participate in the Cantor Global Healthcare Conference?
Vanda's presentation at the Cantor Global Healthcare Conference is scheduled for September 3, 2025.
How can I access the corporate presentations online?
Investors can access the presentations live via Vanda's corporate website under the Investors tab and Recent Events section.
Are there any other conferences Vanda will attend?
Yes, Vanda will also be presenting at the Wells Fargo Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference in September 2025.
Who should I contact for more information about Vanda?
For inquiries, you can reach out to Kevin Moran, Senior VP and CFO at Vanda Pharmaceuticals.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
